{"paper_id":"094663e3-c477-4ff4-82ac-9b9ffb6855db","body_text":"Abstract:\nWe report the case of a woman treated with a gonadotrophin-releasing hormone analogue for endometriosis who developed typical clinical features of fibromyalgia, with widespread musculoskeletal pain, sleep difficulties, neuropsychological complaints and tender points on clininal examination. The gonadotrophin-releasing hormone analogue treatment probably induced disturbances in the neuroendocrine system and the secretion of neurotransmitters, and may be suspected to be the cause of this case of fibromyalgia.\nSimilar content being viewed by others\nAuthor information\nAuthors and Affiliations\nAdditional information\nReceived: 3 May 2000 / Accepted: 25 October 2000\nRights and permissions\nAbout this article\nCite this article\nToussirot, E., Wendling, D. Fibromyalgia Developed after Administration of Gonadotrophin- Releasing Hormone Analogue. Clin Rheumatol 20, 150–152 (2001). https://doi.org/10.1007/PL00011195\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/PL00011195","source_license":"CC0","license_restricted":false}